Apolipoprotein B and Low-Density Lipoprotein Cholesterol are Associated with Left Atrial Enlargement in Patients with Nonvalvular Atrial Fibrillation

被引:0
|
作者
Gong, Bojun [1 ]
Hu, Dajun [2 ]
Li, Zicheng [3 ,4 ]
Zhong, Qiaoqing
机构
[1] Guangzhou Xinju Kee & Trade Dev Co Ltd, Guangzhou, Peoples R China
[2] First Peoples Hosp Chenzhou, Dept Cardiol, Chenzhou, Peoples R China
[3] Jinan Univ, Dept Cardiol, Affiliated Hosp 1, Guangzhou, Peoples R China
[4] Cent South Univ, Xiangya Hosp, Dept Cardiovasc Med, Changsha 410300, Hunan, Peoples R China
关键词
atrial fibrillation; heart atria; humans; arrhythmia; ALPHA-HYDROXYBUTYRATE DEHYDROGENASE; CHA(2)DS(2)-VASC SCORES; THROMBOEMBOLIC RISK; STROKE; CHADS(2); STRATIFICATION; PREVALENCE; PREDICTION; PARAMETERS; MANAGEMENT;
D O I
10.6890/IJGE.202404_18(2).0010
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: Patients who had left atrial enlargement (LAE) with atrial fibrillation (AF) had an increased risk of LA dysfunction. However, there were few reports about the relationship between apolipoprotein B (apo B) and LAE or the association between low -density lipoprotein cholesterol (LDL-C) and LAE. We aimed to evaluated the above relationships in patients with non -valvular atrial fibrillation (NVAF). Methods: A total of 170 subjects were consecutively enrolled from December 2012 to July 2015.87 subjects were retrospectively enrolled as control group. 83 patients were retrospectively included in NVAF group. Heart color Doppler ultrasound examination of all the study subjects were diagnosed by medical specialists. Routine biochemical indicators of hematology were tested in clinical laboratory. Results: There were significant differences between the control and the NVAF group in terms of a - Hydroxybutyrate dehydrogenase ( a -HBDH), triglyceride (TG), total cholesterol (TC) and LDL-C. In total NVAF patients, both the CHADS 2 (r = 0.578, P = 0.000) and CHA 2 DS 2 -VASc (r = 0.632, P = 0.000) scores were positively correlated with age. The CHADS 2 score was negatively correlated with apo B (r = -0.217, P = 0.049), and the CHA 2 DS 2 -VASc score was negatively correlated with TG (r = -0.256, P = 0.019) and calcium ion (CA) (r = -0.285, P = 0.009). In Pearson correlation analysis, LA diameter was negatively correlated with LDL-C (r = -0.425, P = 0.001), apo B (r = -0.407, P = 0.001) and TC (r = -0.378, P = 0.002) in patients with total NVAF accompanied by LAE. Multiple stepwise regression analysis revealed that LDL-C was an important factor influencing LA size in patients with NVAF. Conclusion: In conclusion, apo B and LDL-C was associated with LAE in patients with NVAF, and LDL-C was an important factor influencing LA size in patients with NVAF. Copyright (c) 2024, Taiwan Society of Geriatric Emergency & Critical Care Medicine.
引用
收藏
页码:113 / 117
页数:5
相关论文
共 50 条
  • [21] Serum heparanase levels and left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation
    Yilmaz, Mehmet Fatih
    Acar, Emrah
    Inanir, Mehmet
    Karabay, Can Yucel
    Izgi, Ibrahim Akin
    HERZ, 2022, 47 (03) : 251 - 257
  • [22] Influence of age on left atrial appendage function in patients with nonvalvular atrial fibrillation
    Ilercil, A
    Kondapaneni, J
    Hla, A
    Shirani, J
    CLINICAL CARDIOLOGY, 2001, 24 (01) : 39 - 44
  • [23] Assessment and Management of the Left Atrial Appendage Thrombus in Patients With Nonvalvular Atrial Fibrillation
    Zhan, Yang
    Joza, Jacqueline
    Al Rawahi, Mohamed
    Barbosa, Rodrigo S.
    Samuel, Michelle
    Bernier, Martin
    Thao Huynh
    Thanassoulis, George
    Essebag, Vidal
    CANADIAN JOURNAL OF CARDIOLOGY, 2018, 34 (03) : 252 - 261
  • [24] Left atrial enlargement and non-paroxysmal atrial fibrillation as risk factors for left atrial thrombus/spontaneous Echo contrast in patients with atrial fibrillation and low CHA2DS2-VASc score
    Lin, Wei-Dong
    Xue, Yu-Mei
    Liu, Fang-Zhou
    Fang, Xian-Hong
    Zhan, Xian-Zhang
    Liao, Hong-Tao
    Tse, Gary
    Wu, Shu-Lin
    JOURNAL OF GERIATRIC CARDIOLOGY, 2020, 17 (03) : 155 - 159
  • [25] Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation
    Gloekler, Steffen
    Saw, Jacqueline
    Koskinas, Konstantinos C.
    Kleinecke, Caroline
    Jung, Werner
    Nietlispach, Fabian
    Meier, Bernhard
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 249 : 234 - 246
  • [26] Left Atrial Enlargement is Associated With Anticoagulation Failure in Patients With Acute Ischemic Stroke and Atrial Fibrillation
    Dakay, Katarina
    Chang, Andrew D.
    Hemendinger, Morgan
    Cutting, Shawna M.
    McTaggart, Ryan A.
    Jayaraman, Mahesh V.
    Chu, Antony
    Panda, Nikhil
    Song, Christopher
    Merkler, Alexander
    Gialdini, Gino
    Kummer, Benjamin
    Lerario, Michael P.
    Kamel, Hooman
    Elkind, Mitchell S.
    Furie, Karen L.
    Yaghi, Shadi
    STROKE, 2018, 49
  • [27] Left atrial appendage-occluding devices for stroke prevention in patients with nonvalvular atrial fibrillation
    Yan, Bryan P.
    Kiernan, Thomas J.
    Gonzales-Cruz, Ignacio
    Lam, Yat-Yin
    EXPERT REVIEW OF MEDICAL DEVICES, 2009, 6 (06) : 611 - 620
  • [28] Dabigatran exhibits low intensity of left atrial spontaneous echo contrast in patients with nonvalvular atrial fibrillation as compared with warfarin
    Watanabe, Tetsuya
    Shinoda, Yukinori
    Ikeoka, Kuniyasu
    Inui, Hirooki
    Fukuoka, Hidetada
    Sunaga, Akihiro
    Kanda, Takashi
    Uematsu, Masaaki
    Hoshida, Shiro
    HEART AND VESSELS, 2017, 32 (03) : 326 - 332
  • [29] Left Atrial Appendage Closure in Patients With Intracranial Hemorrhage and Nonvalvular Atrial Fibrillation
    Ajmal, Muhammad
    Naik, Hursh
    Kocheril, Abraham
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2020, 29 (04)
  • [30] Efficacy and safety of rivaroxaban on the resolution of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation patients
    Hong-hong Ke
    Yan He
    Xiang-wei Lv
    En-Hao Zhang
    Zhe Wei
    Jin-yi Li
    Journal of Thrombosis and Thrombolysis, 2019, 48 : 270 - 276